Line 1: |
Line 1: |
− | #https://plot.ly/~scottyn371/11 | + | {{#iDisplay://plot.ly/~scottyn371/11.embed|1300|400}} |
| + | [[Category:Recently Added Pages]] |
| + | [[Category:Copy Number Abnormalities]] |
| + | [[Category:Copy Number Abnormalities in Breast Cancer]] |
| + | |
| + | ==Diagnostic/Prognostic/Therapy Associated CNAs== |
| + | [[ERBB2 Amplification in Breast Carcinoma|ERBB2 Amplification]] |
| + | |
| + | ==Whole Chromosome Gains== |
| + | |
| + | ==Whole Chromosome Losses== |
| + | |
| + | ==Co-Occurring Gains and Losses== |
| + | |
| + | ==Arm-Level Gains== |
| + | |
| + | ==Arm-Level Losses== |
| + | *[[8p Loss in Breast Carcinoma|8p]] |
| + | |
| + | ==Focal Gains== |
| + | |
| + | ==Focal Losses== |
| + | |
| + | ==Known Amplification Targets== |
| + | [[ERBB2 Amplification in Breast Carcinoma|ERBB2]] |
| + | |
| + | ==Known Deletion Targets== |
| + | *[[TP53 Deletion in Breast Carcinoma|TP53]] |
| + | |
| + | |
| + | ==Intragenic and Fusion-Causing CNAs== |
| + | *[[ESR1-CCDC170 Fusion in Breast Carcinoma|ESR1-CCDC170 Fusion]] |